Материал: Донсков С.И., Мороков В.А. Группы крови человека. Руководство по иммуносерологии

48.Michalewska B., Wielgos M., Zupanska B., Bartkowiak R.Anti-Co a implicated in severe haemolytic disease of the foetus and newborn // Transfus. Med. – 2008. – V. 18. –

P.71 −73.

49.Mochizuki K., Ohto H., Hirai S. et al. Hemolytic disease of the newborn due to anti-Di b: a case study and review of the literature // Transfusion. – 2006. – V. 46. – P. 454 −460.

50.Noizat-PirenneF.,LeeK.,LePennecK.Y.etal.RareRHCEphenotypesinblackindividuals of Afro-Caribean origin: identification and transfusion safety // Blood. – 2002. – V. 100. –

P.4223 −4231.

51.Noizat-Pirenne F., Tournamille C., Bierling P. et al. Relative immunogenicity of Fy a and K antigens in a Caucasian population, based on HLA class II restriction analysis // Transfusion. – 2006. – V. 46. – P. 1328 −1333.

52.Noizat-Pirenne F., Tournamille C., Gallon P. et al. ceRA: an RH allele variant producing a new rare blood // Transfusion. – 2006. – V. 46. – P. 1232 −1236.

53.Peyrard T., Pham B.N., Arnaud L. et al. Fatal hemolytic disease of the fetus and newborn associated with anti-Jr a // Transfusion. – 2008. – V. 48. – P. 1906 –1911.

54.Peyrard T., Pham B.N., Poupel S. et al.Alloanti-c / ce in a c +ceAR / Ce patient suggests that the rare RHCE*ceAR allele (ceAR) encodes a partial c antigen // Transfusion. – 2009.  −

V.49. – P. 2 406 −2411.

55.Pham B.N., Peyrard T., Juszczak G. et al. Alloanti-c (RH4) revealing that the (C)ce s haplotype encodes a partial c antigen // Transfusion – 2009.  − V. 49. – P. 1329 −1334.

56.Pham B.N., Peyrard T., Juszczak G. et al. Heterogeneous molecular background of the weak C, VS +, hr B −, Hr B − phenotype in black persons // Transfusion. – 2009. – V. 49. –

P.495 −504.

57.Pham B.N., Peyrard T., Tourret S. et al. Anti-Hr B and anti-hr B revisited // Transfusion. – 2009. – V. 49. – P. 2400 −2405.

58.Picard C., Frassati C., Basire A. et al. Positive association of DRB1*04 and DRB1*15 alleles with Fy a immunization in a Southern European population // Transfusion. – 2009. –

V.49. – P. 2412 −2417.

59.Polin H., Danzer M., Gaszner W. et al. Identification of RHD alleles with the potential of anti-D immunization among seemingly D– blood donors in UpperAustria // Transfusion. – 2009. – V. 49. – P. 676 −681.

60.Poole J., Warke N., Hustinx H. et al. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen // Transfusion. – 2006. – V. 46. –

P.1879 −1885.

61.Reid M.E., Lomas-Francis C. The Blood GroupAntigen: FactsBook. – 2-nd ed. – London: Academic Press, 2004. – 561 p.

62.Richard M., Perreault J., Constanzo-Yanez J. et al. A new DEL variant caused by exon 8 deletion // Transfusion. – 2007 – V. 47. – P. 852  −857.

63.RichardM.,PerreaultJ.,GaneP.etal.Phage-derivedmonoclonalanti-Lu a //Transfusion.– 2006. – V. 46. – P. 1011 −1017.

64.Selleng S., Selleng K., Zawadzinski C. et al. Management of emergency cardiac surgery in a patient with alloanti-Ge2 // Transfus. Medi. – 2009 – V. 19. – P. 50 −52.

1011

65.SeltsamA.,AgaylanA.,GruegerD.etal.Rapiddetectionofanti-Lu b withrecombinant Lu b protein and the particle gel immunoassay // Transfusion. – 2008. – V. 48. –

P.731 – 734.

66.Seltsam A., Agaylan A., Grueger D. et al. Rapid detection of JMH antibodies with recombinant Sema7A (CD108) protein and the particle gel immunoassay // Transfusion. – 2008. – V. 48. – P. 1151–1155.

67.Seltsam A., Grueger D., Blasczyk R., Flegel W.A. Easy identification of antibodies to high-prevalence Scianna antigens and detection of admixed alloantibodies using soluble recombinant Scianna protein // Transfusion. – 2009. – V. 49. – P. 2090 −2096.

68.Seltsam A., Strigens S., Levene C. et al. The molecular diversity of Sema7A, the semaphorin that carries the JMH blood group antigens // Transfusion. – 2007. – V. 47. –

P.133 −146.

69.Touinssi M., Chapel-Fernandes S., Granier T. et al. Molecular analysis of inactive and active RHD alleles in native Congolese cohorts // Transfusion. – 2009. – V. 49. –

P.1353 −1360.

70.Tournamille C., Meunier-Costes N., Costes B. et al. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization // Transfusion. – 2010.  −

V.50. – P. 13 −19.

71.Van Gammeren A.J., Overbeeke M. A. M., Idema R.N. et al. Haemolytic disease of the newborn because of rare anti-Vel // Transfus. Med. – 2008. – V. 18. – P. 197 −198.

72.Velliquette R.W, Palacajornsuk P., Hue-Roye K. et al. Novel GYP(A-B-A) hybrid gene in a DANE + person who made an antibody to a high-prevalence MNS antigen //Transfusion. – 2008. – V. 48. – P. 2618 −2623.

73.Velliquette R.W., Sausais L., Lomas-Francis C. et. al. Two novel and related high- prevalenceantigensintheKellbloodgroupsystem//Trasfusion.–2007.–V.47(Suppl.).– 164A −165A(Abstract).

74.Walker R.H., Danek A., Uttner I. et al. McLeod phenotype without the McLeod syndrome

//Transfusion. – 2007.  − V. 47.  − P. 299 −305.

75.Warke N., Poole J., Mayer B. et al. New antigen in the Dombrock blood group system: DOYA// Trasfusion. – 2006. – V. 46 (Suppl.). – 209A(Abstract).

76.Wester E.S., Johnson S.T., Copeland T. et al. Erythroid urea transporter deficiency due to novel JKnull alleles // Transfusion. – 2008 – V. 48. – P. 365 −372.

77.Westhoff C., Vege V., Yazdanbakhsh K. et al. A DOB allele encoding an amino acid substitution (Phe62Ser) resulting in a Dombrock null phenotype // Transfusion. – 2007. –

V.47. – P. 1356 −1362.

78.Westhoff C.M., Vege S., Wylie D. et al. The JAL antigen (RH48) is the result of a change in RHCE that encodesArg114Trp // Transfusion. – 2009.  − V. 49. – P. 725 −732.

79.Win N, Needs M. Anti-Cr a: pregnancy and transfusion support // Immunohematology. – 2006. – V. 22. – P. 203.

80.Win N., Needs M., Tilliyer L. Management of pregnancy complicated by anti-hr B / anti-Hr B

//Immunohematology. – 2007. – V. 23. – P. 143 −145.

1012

81.Yabe R., Enomoto T., Satake M., Nakajima K. Molecular basis for a novel low-frequency antigen in the Kell blood group system, KYO // Vox Sang. – 2006. – V. 91 (Suppl. 3). – P. 25S.

82.Yan L., Wu J., Zhu F., Hong X., Xu X. Molecular basis of D variants in Chinese persons // Transfusion – 2007. – V. 47. – P. 471 −477.

83.Yang Y., Wang L.L., Wang C. et al. Two novel null alleles of the KEL gene detected in two Chinese women with the Knull phenotype // Transfus. Med. – 2009. – V. 19. – P. 235 −244.

84.Ye L., Yue D., Wo D. et al. Molecular bases of unexpressed RHD alleles in Chinese D– persons // Transfusion. – 2009.  − V. 49. – P. 1655 −1660.

85.YuanS.,ArmourR.,ReidA.etal.Casereport:massivepostpartumtransfusionofJr(a + )cell in the presence of anti-Jr a // Immunohematology. – 2005. – V. 21. – P. 97 −101.

86.Yuan S., Ewing N.P., Bailey D. et al. Transfusion of multiple units of Js(a + ) red blood cells in the presence of the anti-Js b in a patient with sickle β-thalassemia disease and the review of literature // Immunohematology. – 2007. – V. 23. – P. 75-80.

1013

Список сокращений

АЕТ – 2-аминоэтилизотиоурониумбромид АИГА – аутоиммунная гемолитическая анемия ГБН – гемолитическая болезнь новорожденного ДНК– дезоксирибонуклеиновая кислота гДНК – геномная ДНК кДНК – кодирующая ДНК ДТТ – дитиотрейтол

ИТП – идиопатическая тромбоцитопеническая пурпура кб – килобаза (Kb) = 10 3 bp

bp – пара оснований = пн кДа – килодальтон

МКА – моноклональные антитела ОГР – отсроченные гемолитические реакции ПААГ – полиакриламидный гель пн – пара нуклеотидов

ПТО – посттрансфузионное осложнение ПЦР – полимеразная цепная реакция СПИД – синдром иммунодефицита ХГМ – хронический гранулематоз

ХПН – хроническая почечная недостаточность ЭДТА – этилендиаминтетроуксусная кислота GPI – гликозилилфосфатидилинозотол

IgM, IgG, IgA– иммуноглобулины класса M, G,A

ISBT (Internationl Society of Blood Transfusion) – Международное общество трансфузиологов

LISS (Low ionic-strength solution) – раствор с низкой ионной силой

ZZAP– сульфгидрильные редуценты в комбинации с протеолитическими ферментами (дитиотрейтол с папаином, активированным цистеином)

1014

Обозначение аминокислот

1015